Correction: An integration of complementary strategies for gene-expression analysis to reveal novel therapeutic opportunities for breast cancer by Bild, Andrea H et al.
In our previous publication [1], Figure 4 involved the 
analysis of chemotherapy-response signatures (as carried 
out independently by author AP and described in a 2006 
Nature Medicine article [2,3]). It has recently been 
determined that the chemotherapy-response signatures 
in [2] are not reproducible, causing retraction of that 
article [3]. As such, the results presented in Figure 4 of 
our original paper [1] are no longer valid.
We believe that the data presented in Figures 1-3 of our 
article remain valid. However, as Figure 4 can no longer 
be considered valid, portions of [1] are no longer 
applicable, including the Materials and Methods section 
entitled “Chemosensitivity signatures”, the Results sec-
tion entitled “Genomic signatures that predict response 
to cytotoxic chemotherapeutics”, and other statements in 
the Abstract, Introduction, Results, Discussion, and 
Conclusions sections that refer directly or indirectly to 
the integration of chemotherapy-response signatures into 
the analytical approach presented in the manuscript.  As 
such, the focus of the manuscript on the utility of an 
integrated approach using three complementary strate  gies 
for gene expression analysis (i.e. breast cancer intrinsic 
subtype analysis, pathway prediction and chemo  therapy-
response signatures) should now be interpreted as 
referring exclusively to the integration of two comple-
men tary  strategies.
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